Soluble protein encoded by CD44 variant exons 8-10 in the serum of patients with colorectal cancer

British Journal of Surgery

Volumn 84, Issue 10, 1997, Pages 1452-1453

  Goi, T ^a   Yamaguchi, A ^b   Seki, K ^a   Nakagawara, G ^a   Urano, T ^b   Shiku, H ^a   Furukawa, K ^b  

^a Fukui Medical University   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; HERMES ANTIGEN;

ARTICLE; BLOOD; COLORECTAL TUMOR; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; HUMAN; IMMUNOHISTOCHEMISTRY;

ANTIGENS, CD44; BACTERIAL PROTEINS; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXONS; HUMANS; IMMUNOHISTOCHEMISTRY;

EID: 0031255845     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800841031     Document Type: Article

References (5)

1. Lesley J, Hyman R, Kincade PW. CD44 and its interaction with extracellular matrix. Advjmnwnol 1993; 54: 271-335.
2. Hofmann M, Rudy W, Zöller M et al. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 1991; 51: 5292-7.
3. Tanabe KK, Ellis LM, Saya H. Expression of CD44R1 adhesion molecule in colon carcinomas and métastases. Lancet 1993; 341: 725-6.
4. Goi T, Yamaguchi A, Takeuchi K et al. CD44 with variant exons 8-10 in colorectal tumors: expression analysis by a variant exon 9-specific monoclonal antibody. Int J Oncol 1996; 8: 657-62.
5. Yamaguchi A, Urano T, Goi T et al. Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients. J Clin Oncol 1996; 14: 1122-7.